Watch the full video to learn how it actually works to reduce melanin and brighten your skin tone from within
In this group, not only lipid-lowering therapy is important (in these patients, lipid disorders may occur as often as in general population), but particular attention should be paid to possible drug interactions, especially as these patients often receive multiple concomitant medications
1 in 8 people are now using GLP-1 medications
For patients with Crohn's disease, these effects could potentially: Mimic or mask disease flare symptoms, making it difficult to distinguish medication side effects from disease activity Exacerbate existing gastrointestinal symptoms, reducing quality of life Complicate nutritional management and absorption of other medications Increase the risk of dehydration, particularly if diarrhoea is already present Serious risks associated with GLP-1 receptor agonists include: Acute pancreatitis : Patients should be advised to seek immediate medical attention if they experience severe, persistent abdominal pain radiating to the back, as this may indicate pancreatitis
Plasma physics of liquidsA focused review
